3A4, a new potential target for B and myeloid lineage leukemias.

about

Immunotoxins for leukemia.ZCH-2B8a, an antibody targeting actin-binding protein coronin-1a, is a potential therapeutic agent for B-lineage malignancies.

P2860

Q37709336-7758074E-DE4E-413F-B61B-6394744B4715 Q39023022-9E7BFAB1-B864-4542-99DA-00B30C19CAB9

P2860

3A4, a new potential target for B and myeloid lineage leukemias.

Item

http://www.wikidata.org/entity/Q39556254

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

3A4, a new potential target for B and myeloid lineage leukemias.

@en

3A4, a new potential target for B and myeloid lineage leukemias.

@nl

type

Item

label

3A4, a new potential target for B and myeloid lineage leukemias.

@en

3A4, a new potential target for B and myeloid lineage leukemias.

@nl

prefLabel

3A4, a new potential target for B and myeloid lineage leukemias.

@en

3A4, a new potential target for B and myeloid lineage leukemias.

@nl

P1476

3A4, a new potential target for B and myeloid lineage leukemias.

@en

P2093

Hongqiang Shen

http://www.w3.org/2001/XMLSchema#string

Jingying Zhang

http://www.w3.org/2001/XMLSchema#string

Sisi Li

http://www.w3.org/2001/XMLSchema#string

Xiaoping Guo

http://www.w3.org/2001/XMLSchema#string

Yongmin Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous cultures of fused cells secreting antibody of predefined specificity

Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia

Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.

CD45: a critical regulator of signaling thresholds in immune cells.

Lymphokine regulation of CD45R expression on human T cell clones.

CD45: all is not yet crystal clear.

Accurate determination of internalization for target binding antibody using papain digestion and flow cytometry.

Mechanism of internalization of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans.

Binding and internalization of anti-sarcoma IgG and IgM antibodies.

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study.

P304

797-804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/1061186X.2011.572973

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21504388

http://www.w3.org/2001/XMLSchema#string

3A4, a new potential target for B and myeloid lineage leukemias.

about

P2860

P2860

3A4, a new potential target for B and myeloid lineage leukemias.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698